Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record now indicates that it is no longer recruiting participants, clarifying that enrollment has ceased. A new revision marker v3.6.0 was added and the previous marker v3.5.5 was removed, updating the version history of the record.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page's revision metadata updated from v3.5.4 to v3.5.5, indicating a new version of the page that tracks historical edits.SummaryDifference0.0%

- Check40 days agoChange DetectedThe record history now displays Revision: v3.5.4, replacing Revision: v3.5.3. This signals a new release version of the history interface.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.5.3 now appears, replacing Revision: v3.5.2. This indicates a small backend or template update without altering the study data or visible content.SummaryDifference0.0%

- Check69 days agoChange DetectedFooter revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check98 days agoChange DetectedThe history log now lists a new revision version v3.5.0 and the deletion of v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.